Novelon

Formulated to address contraception needs to support pregnancy prevention.

Strengths: 0.15/0.3mg

Medicine details

Conditions
Alternative names

Marvelon; Mercilon; Femilon; Desogestrel and Ethinyl Estradiol Tablets

Therapeutic class

Combined oral contraceptive

Pharmacological class

Progestogen and oestrogen, fixed-dose

Minor side effects

nausea; abdominal pain; weight gain; headache; breast tenderness

Moderate side effects

mood swings; decreased libido; migraine

Dosage forms

Tablet

Administration route

Oral use

Patient summary

Formulated to address contraception needs to support pregnancy prevention.

Prescription status

POM

Manufacturer

Organon

Onset Time

1–3 months

Duration

Cycle dependent

Storage instructions

Store at room temperature in a dry place away from light.

Drug interactions

Anticonvulsants; St. John's Wort; Rifampicin

Age restrictions

For use in individuals of reproductive age.

Contraindications

history of venous thromboembolism; history of arterial thromboembolism; migraine with aura; severe hypertension; hepatic tumour; pregnancy

Precautions and warnings

increases risk of venous thrombosis; regular blood pressure monitoring recommended; may alter mood; discontinue if jaundice occurs

Serious side effects

venous thromboembolism — requires immediate medical attention; arterial thromboembolism — requires immediate medical attention; hypertension — requires immediate medical attention

Mechanism of action

This medicine suppresses ovulation by inhibiting gonadotropin secretion and increases the viscosity of cervical mucus to prevent sperm penetration.

Pregnancy and breastfeeding

Pregnancy: Do not use if pregnant. Breastfeeding: Not recommended as it may reduce milk production.

Novelon

Formulated to address contraception needs to support pregnancy prevention.

Editorial Notes

  • Active ingredient(s): Desogestrel, Ethinyl Estradiol
  • Listed indication(s): Contraception

Available option

  • 105 tablets - 0.15/0.3 mg1471-0-15-0-3-mg-17695